18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T71765 | CQ | ||
CQ is a potent inhibitor of alpha-glucosidase | |||
T8689 | Chloroquine | CQ | SARS-CoV , TLR , HIV Protease , Antibiotic , Parasite , Autophagy |
Chloroquine is a Toll-like receptor inhibitor that inhibits autophagy. Chloroquine has anti-malarial and anti-inflammatory activity and is widely used in the treatment of malaria and rheumatoid arthritis. Chloroquine als... | |||
TQ0068 | NVP-LCQ195 | AT9311,LCQ-195 | CDK |
NVP-LCQ195 (LCQ-195) (AT9311) is a potent inhibitor of CDK1, CDK2, CDK3 and CDK5 (IC50: 1-42 nM). | |||
T63642 | CQ211 | Others | |
CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM.CQ211 has shown potent proliferation inhibitory activity against various cancer cell lines in vitro. | |||
T21965 | MBCQ | PDE | |
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5. | |||
T7008 | Vacquinol-1 | Vacquinol 1 | JNK |
Vacquinol-1 is an MKK4 activator, which rapidly and selectively induces glioma cell death. | |||
T72107 | Werner syndrome RecQ helicase-IN-1 | DNA/RNA Synthesis | |
Werner syndrome RecQ helicase-IN-1 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer. | |||
T72110 | Werner syndrome RecQ helicase-IN-4 | ||
Werner syndrome RecQ helicase-IN-4 is a potent, orally active inhibitor of Werner syndrome RecQ helicase (WRN) with an IC50 of 0.06 µM, exhibiting both antiproliferative and anticancer activities. | |||
T72109 | Werner syndrome RecQ helicase-IN-3 | ||
Werner syndrome RecQ helicase-IN-3, a potent and orally active inhibitor of Werner syndrome RecQ helicase (WRN), exhibits anticancer and antiproliferative activities with an IC50 value of 0.06 µM. | |||
T124235 | Jacquinelin | ||
Jacquinelin is a useful organic compound for research related to life sciences. The catalog number is T124235 and the CAS number is 7726-34-3. | |||
T63899 | RECQL5-IN-1 | ||
RECQL5-IN-1 is an orally active inhibitor of RECQL5 (targeting both enzymatic and non-enzymatic domains) and is a potent inhibitor of RECQL5 decapping activity (IC50 46.3 nM): RECQL5-IN-1 can be used to study breast canc... | |||
T72108 | Werner syndrome RecQ helicase-IN-2 | ||
Werner syndrome RecQ helicase-IN-2 (example 57), a potent inhibitor of the Werner syndrome RecQ DNA helicase enzyme (WRN), holds potential for use in cancer research. | |||
T71617 | NCQ-469 | ||
NCQ-469 is a metabolite of remoxipride and a dopamine D2 receptor antagonist. | |||
T33699 | NLCQ-1 HCl | NLCQ1,NLCQ-1, NLCQ 1,NSC 709257 | |
NLCQ-1 is a novel weak DNA-intercalative bioreductive compound. NLCQ-1 exhibited a C50 of 44 microM. NLCQ-1 demonstrated significant hypoxic selectivity in several rodent (V79, EMT6, SCCVII) or human (A549, OVCAR-3) tumo... | |||
T31227 | DCQVA | ||
DCQVA is a biochemical. | |||
T28220 | NVP ACQ090 | NVP-ACQ090,ACQ090,ACQ 090,NVPACQ090,ACQ-090 | |
NVP ACQ090 is a potent and subtype-selective somatostatin sst(3) receptor antagonist. | |||
T63655 | Antimalarial agent 9 | ||
Antimalarial agent 9 is an effective antimalarial agent, a quinoline-imidazole derivative compound. antimalarial agent 9 showed significant in vitro antimalarial effects against CQ-susceptible strains (IC50-0.14 μM) and ... | |||
T61058 | JMI-105 | ||
JMI-105 has the potential as an antimalarial agent. JMI-105 is a potent inhibitor of Plasmodium falciparum falcipain-2 protease (PfFP-2) that inhibits the P. falciparum strains CQ S (3D7) and CQ R (RKL-9) growth with IC ... |